Europe — EMA
Mirtazapine Focus Pharmaceuticals Ltd
GNH USA supplies Mirtazapine Focus Pharmaceuticals Ltd (Mirtazapine), a tetracyclic antidepressant for major depressive disorder. Request a quote for supply.
Request sourcing
What is Mirtazapine?
Mirtazapine, the active ingredient in Mirtazapine Focus Pharmaceuticals Ltd, is a tetracyclic antidepressant presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients and is manufactured under EU GMP standards as a prescription‑only medicine.
GNH USA supplies Mirtazapine Focus Pharmaceuticals Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Mirtazapine used for?
Mirtazapine is indicated for depressive disorders and works by modulating neurotransmitter activity.
Major depressive disorder: alleviates depressive symptoms and improves mood in adult patients.
What are the side effects of Mirtazapine?
Mirtazapine may cause a range of adverse reactions that are classified by frequency.
Common Side Effects: - Sedation: drowsiness or sleepiness, especially at treatment initiation. - Increased appetite and weight gain: heightened hunger leading to weight increase. - Dry mouth: reduced salivation causing oral dryness. - Constipation: slowed gastrointestinal motility. - Dizziness: light‑headed sensation on standing.
Serious or Rare Side Effects: - Severe neutropenia: marked reduction in white blood cells. - Serotonin syndrome: potentially life‑threatening reaction when combined with serotonergic agents. - Hypotension: significant drop in blood pressure causing faintness. - Suicidal thoughts: emergence or worsening of suicidal ideation.
What precautions apply to Mirtazapine?
Before prescribing Mirtazapine, clinicians should consider several safety factors. - Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: unknown excretion; consider alternatives. - Elderly patients: monitor for increased sedation and falls. - History of bipolar disorder: risk of mood switching to mania. - Concomitant CNS depressants: may enhance sedative effects. - Store at ambient temperature: keep in original container, protect from moisture and light.
What does Mirtazapine interact with?
Mirtazapine interacts with several drug classes; awareness helps prevent adverse events.
Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis; discontinue MAOI at least 14 days before starting. - Serotonergic agents (SSRIs, SNRIs, triptans): risk of serotonin syndrome. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase mirtazapine plasma levels. - Alcohol: additive CNS depression. - CNS depressants (benzodiazepines, opioids): heightened sedation.
Moderate Interactions (Monitor Closely): - CYP3A4 inducers (rifampicin, carbamazepine): may reduce effectiveness. - Anticholinergic drugs: additive dry mouth. - Antihypertensives: possible additive hypotensive effect. - Lithium: monitor for increased sedation. - Warfarin: monitor INR as mirtazapine may affect clotting.
Frequently asked questions
What is Mirtazapine used for?+
How does Mirtazapine work?+
What is the usual dose of Mirtazapine?+
Is Mirtazapine safe in pregnancy or breastfeeding?+
How do I order Mirtazapine from GNH USA?+
How does Mirtazapine compare with other antidepressants?+
How should Mirtazapine be stored and handled?+
How is Mirtazapine administered?+
What are the most serious risks to watch for with Mirtazapine?+
Who should not use Mirtazapine?+
Product details
Related products

Mirtazapine 15 mg/1
Mirtazapine · 15 mg

Mirtazapine 15 mg/1
Mirtazapine · 15 mg

Mirtazapine 15 mg/1
Mirtazapine · 15 mg

Mirtazapine 30 mg/1
Mirtazapine · 30 mg